HCS
BIIB icon

Himension Capital (Singapore)’s Biogen BIIB Stock Holding History

Himension Capital (Singapore)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-998
Closed -$256K – 44
2023
Q3 		$256K Buy
+998
New +$267K 0.03% 71

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Himension Capital (Singapore)'s BIIB Position: Q4 2023 in Review

Himension Capital (Singapore) sold out of Biogen (BIIB) in Q4 2023, closing a stake of 998 shares — an estimated $256K sold.

Himension Capital (Singapore) first reported a position in BIIB in Q3 2023 and held it in 1 quarter. The position peaked at $256K in Q3 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • Himension Capital (Singapore) reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • Himension Capital (Singapore) sold 998 Biogen shares in Q4 2023, an estimated $256K.
  • Himension Capital (Singapore) first reported a position in Biogen in Q3 2023 and held it in 1 quarter.
  • Himension Capital (Singapore)'s Biogen position peaked at $256K in Q3 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Himension Capital (Singapore)'s 13F filing for Q4 2023, filed 14 Feb 2024.